Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 37
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients
Qian Wu, Hairuo Wu, Yabin Hu, et al.
Antiviral Research (2025), pp. 106092-106092
Closed Access | Times Cited: 1
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
H. J. Yang, Weiqi Hong, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
Danyi Ao, Dandan Peng, Cai He, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
Rafael Rahal Guaragna Machado, Erika Donizette Candido, Andressa Simões Aguiar, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 144-144
Open Access | Times Cited: 6
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China
Xin‐Jing Zhao, Xiaolin Liu, Yu‐Min Liang, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Open Access | Times Cited: 4
Humoral immune response characteristics of vulnerable populations against SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB
Huan Zhang, Shi Ouyang, Yunhui Qu, et al.
Archives of Virology (2025) Vol. 170, Iss. 4
Closed Access
Humoral immune response characteristics of the elderly, children and pregnant women after XBB infection
Fen Ouyang, Huan Zhang, Yushan Jiang, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. e96-e99
Closed Access | Times Cited: 9
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients
Prapassorn Poolchanuan, Wasin Matsee, Adul Dulsuk, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months
Qin Luo, Qinqin Song, Yan Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
Syamala Rani Thimmiraju, Rakesh Adhikari, María José Villar, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1557-1557
Open Access | Times Cited: 8
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials
H. J. Yang, Weiqi Hong, Shi H, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
Keda Chen, Ling Zhang, Zhongbiao Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
Sharon Walmsley, Majid Nabipoor, Freda Qi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 564-564
Open Access | Times Cited: 2
XBB: the chosen one from SARS-CoV-2 homologous recombination
Qi Chen, Pan‐Deng Shi, Cheng‐Feng Qin
Life Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
Xuan He, Jiajing Jiang, Li Guo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Longitudinal Analysis of Neutralizing Antibodies Against SARS-CoV-1 and Different SARS-CoV-2 Strains in Breakthrough and Unvaccinated Covid-19 Patients in Thailand
Prapassorn Poolchanuan, Vichapon Tiacharoen, Adul Dulsuk, et al.
(2024)
Closed Access | Times Cited: 1
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants
Sneha Vishwanath, George Carnell, Martina Billmeier, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination
Tingting Jia, Fuxiang Wang, Y Chen, et al.
Journal of Infection (2024) Vol. 89, Iss. 6, pp. 106362-106362
Open Access | Times Cited: 1
Antibody screening-assisted multichannel nanoplasmonic sensing chip based on SERS for viral screening and variants identification
Yi Liu, Huanjiao Weng, Zhiwei Chen, et al.
Biosensors and Bioelectronics (2024) Vol. 271, pp. 117015-117015
Closed Access | Times Cited: 1
Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection
Yu Lei, Nansong Xu, Chuanying Niu, et al.
Virology (2024) Vol. 597, pp. 110142-110142
Closed Access | Times Cited: 1
Epidemiological characteristics of first-time SARS-CoV-2 Omicron infection among hospital staff in Chengdu, China
Li Tang, Yeyuan Wang, Xue Li, et al.
Journal of Health Population and Nutrition (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Evaluation of cross‐neutralizing immunity following COVID‐19 primary series vaccination during the Omicron surge in Tanzania
Lilian Nkinda, Godfrey Barabona, Isaac Ngare, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top